The two-way contract didn’t exist prior to 2017, but it’s now in its third year of existence and has injected some additional talent into the G League, writes Eric Pincus of Bleacher Report.
“It’s added a lot of depth. The talent and skill level are at a different point than when I first came into the league as a player and as a coach,” South Bay Lakers coach Coby Karl said. “Over the last three years, it’s a completely different experience. … The young, talented guys were going overseas because there wasn’t enough money in the G League.”
While a two-way player still won’t earn as much as an NBA rookie on a standard, minimum-salary contract, that two-way player can earn up to about $411K this season if he maxes out his 45 NBA days, per cap expert Albert Nahmad (Twitter link). It also gives more young players a chance to enter an NBA team’s developmental program.
“I don’t love those contracts. They don’t really do anything for me,” one agent told Pincus. “They’re not very agent-friendly, but they’re a necessary vehicle. … [My clients] are getting in the door with an organization. They’re able to see the floor, to be a priority guy in the G League program while developing.”
Here are more odds and ends from around the basketball world:
- Cole Anthony (UNC) and R.J. Hampton (New Zealand) have fallen out of the top five in ESPN’s latest big board for the 2020 NBA draft, having been displaced by Tyrese Haliburton (Iowa State) at No. 4 and Deni Avdija (Israel) at No. 5.
- In his latest newsletter, Marc Stein of The New York Times hands out his “Best of the Decade” awards, including his pick for Transaction of the Decade: The Lakers‘ aborted trade for Chris Paul way back in 2011.
- David Aldridge of The Athletic explains why he isn’t a fan of the NBA’s proposed midseason tournament or the idea of giving the No. 10 team in each conference a chance to make the postseason via a play-in tournament.
- Former NBA player Al Harrington is advocating for the league to allow players to use CBD, a form of marijuana. Candace Buckner of The Washington Post has the full story on Harrington’s work since he retired as a player, and why he’s pushing for the NBA to relax its anti-drug policy.
Not any research on CBD for its claimed effects unless your a child with some types of epilepsy. Right now it is another type of snake oil. Not sure what Harrington’s angle is but I would guess he plans on marketing it for its scientifically unsupported effects.
do some research yourself before you claim you know what your talking about
Feel free to show me my mistakes otherwise your statement is meaningless.
don’t have time to waste on idiots
actually i apologize. that was out of line. however just bc you don’t think there’s any medical benefits to something you don’t use or doesn’t work for you does not mean that it has no medical benefit to someone else
It’s not me…If the medical arm of the NBA conducts their own analysis they will conclude that not enough is known to approve cbd oil. Just because Harrington and an MD have teamed up is not evidence of anything other than their desire to cash in on the cbd craze. The FDA has only approved its medical use for kids with certain types of epilepsy. Any other positive effects reported by individual testimonials are due to the placebo effect.
*you’re
Research on the similar cannibus missed the mark on all effects, both good (longevity or stress-beating) and bad (such as grumpiness from longterm use, still using or not). IDK about CBD.
Owner-proprietor quick-grocery stores might like the revenue they could bring. It could bring back the old head shops!
Or a version of hookah hangouts.
If the medical arm of the NBA conducts their own analysis they will conclude that not enough is known to approve cbd oil. Just because Harrington and an MD have teamed up is not evidence of anything other than their desire to cash in on the cbd craze. The FDA has only approved its medical use for kids with certain types of epilepsy. Any other positive effects reported by individual testimonials are due to the placebo effect.